Patients treated with sitagliptin exhibited a significant mean decrease from baseline in body weight compared to a significant weight gain in patients administered glipizide (-1.5 kg vs
Subsequently, the clinical efficacy and safety of the PEGylated co-agonist was evaluated in a chronic ascending-dose study wherein 53 patients with T2D received once-weekly injections of 4, 12, 20, or 30 mg of the PEGylated co-agonist or placebo for 6 weeks
Bariatric Surgery: All surgeries have risks involved
The glucagon receptor activation at 8mg and above drives significant lipolysis and fat oxidation, which, combined with adequate protein intake and resistance training , may preserve lean tissue better than lower doses
The GLP-1 Connection GLP-1 is a naturally occurring hormone that plays a central role in controlling hunger and sending fullness cues, glucose metabolism and insulin response, how your body burns calories and stores energy, and gastric emptying and digestion
Serious adverse events from GLP-1 therapy are uncommon in medically supervised programs